Quality of life under extended continuous versus intermittent adjuvant letrozole in lymph node-positive, early breast cancer patients: the SOLE randomised phase 3 trial

- Ribi, Karin, Luo, Weixiu, Ruhstaller, Thomas, Abdi, Ehtesham, Biganzoli, Laura, Müller, Bettina, Barbeaux, Annelore, Graas, Marie-Pascale, Rabaglio, Manuela, Francis, Prudence A., Foukakis, Theodoros, Pagani, Olivia, Colleoni, Marco, Graiff, Claudio, Vorobiof, Daniel, Maibach, Rudolf, Di Leo, Angelo, Gelber, Richard D., Goldhirsch, Aron, Coates, Alan S., Regan, Meredith M., Bernhard, Jürg, Karlsson, Per, Chirgwin, Jacquie, Aebi, Stefan, Jerusalem, Guy, Neven, Patrick, Di Lauro, Vincenzo, Gomez, Henry L.

Treatment efficacy, adherence, and quality of life among women younger than 35 years in the International Breast Cancer Study Group TEXT and SOFT adjuvant endocrine therapy trials

- Fleming, Gini F., Saha, Poornima, Burstein, Harold J., Parmar, Vani, Torres, Roberto, Stewart, Josephine, Bellet, Meritxell, Perello, Antonia, Dane, Faysal, Moreira, Antonio, Vorobiof, Daniel, Nottage, Michelle, Regan, Meredith M., Price, Karen N., Coates, Alan S., Goldhirsch, Aron, Gelber, Richard D., Colleoni, Marco, Pagani, Olivia, Francis, Prudence A., Walley, Barbara A., Ribi, Karin, Bernhard, Jurg, Luo, Weixiu, Gomez, Henry L.